Zurcher Kantonalbank (Zurich Cantonalbank) Apellis Pharmaceuticals, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 20,348 shares of APLS stock, worth $511,752. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,348
Previous 19,212
5.91%
Holding current value
$511,752
Previous $554,000
17.15%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$307 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$299 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$297 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$253 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$242 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.76B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...